Tackling Alzheimer’s: who benefits from current spending?

11 by / on 7 Jul 2014, / in dementia

Is putting all our eggs in the drug basket really the best way to beat Alzheimer’s? Just as we can’t rely on drug companies alone to beat antibiotic resistance, so we can’t rely on a pharmaceutical silver bullet for Alzheimer’s. Tackling antibiotic resistance needs heavy investment in drugs that will be used sparingly for a short time. The pharma model prefers drugs for as many people as possible for as long as possible. (Read More…)